New lipid formulation of octenidine dihydrochloride

References

• Al-Doori Z, Goroncy-Bermes P, Gemmell CG, Morrison D. (2007). Low-level exposure of MRSA to octenidine dihydrochloride does not select for resistance. J Antimicrob Chemother 59:1280–1
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. (2013). Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65:36–48
   PubMed Web of Science ®Google Scholar
• Barenholz Y. (2001). Liposome application: problems and prospects. Curr Opin Colloid Interf Sci 6:66–77
   Web of Science ®Google Scholar
• Bartok M, Tandon R, Alfaro-Espinoza G, et al (2015). Reduction of cytotoxicity of benzalkonium chloride and octenidine by brilliant blue G. Excli J 14:123–32
   PubMed Web of Science ®Google Scholar
• Becker LC. (2008). Final report on the safety assessment of 3-methylamino-4-nitrophenoxyethanol as used in hair dyes. Int J Toxicol 27:41–51
   PubMed Web of Science ®Google Scholar
• Becker LC, Bergfeld WF, Belsito DV, et al (2010). Amended safety assessment of dodecylbenzenesulfonate, decylbenzenesulfonate, and tridecylbenzenesulfonate salts as used in cosmetics. Int J Toxicol 29:288s–305s
   PubMed Web of Science ®Google Scholar
• Brill F, Goroncy-Bermes P, Sand W. (2006). Influence of growth media on the sensitivity of Staphylococcus aureus and Pseudomonas aeruginosa to cationic biocides. Int J Hyg Environ Health 209:89–95
   PubMed Web of Science ®Google Scholar
• Brooks BD, Brooks AE. (2014). Therapeutic strategies to combat antibiotic resistance. Adv Drug Deliv Rev 78:14–27
   PubMed Web of Science ®Google Scholar
• Buckley ST, Frank KJ, Fricker G, Brandl M. (2013). Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations”. Eur J Pharm Sci 50:8–16
   PubMed Web of Science ®Google Scholar
• Carmona-Ribeiro AM, Carrasco LDD. (2014). Novel formulations for antimicrobial peptides. Int J Mol Sci 15:18040–83
   PubMed Web of Science ®Google Scholar
• Chen ML. (2008). Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective. Adv Drug Deliv Rev 60:768–77
   PubMed Web of Science ®Google Scholar
• Cone RA. (2009). Barrier properties of mucus. Adv Drug Deliv Rev 61:75–85
   PubMed Web of Science ®Google Scholar
• Cu Y, Saltzman WM. (2009). Drug delivery: stealth particles give mucus the slip. Nat Mater 8:11–13
   PubMed Web of Science ®Google Scholar
• Daeschlein G. (2013). Antimicrobial and antiseptic strategies in wound management. Int Wound J 10:9–14
   PubMed Web of Science ®Google Scholar
• de Lucena JMVM, Decker EM, Walter C, et al (2013). Antimicrobial effectiveness of intracanal medicaments on Enterococcus faecalis: chlorhexidine versus octenidine. Int Endod J 46:53–61
   PubMed Web of Science ®Google Scholar
• Dissemond J, Augustin M, Eming SA, et al (2014). Modern wound care - practical aspects of non-interventional topical treatment of patients with chronic wounds. J DTSCH Dermatol Ges 12:541–53
   PubMed Web of Science ®Google Scholar
• European Committee for Standardisation. (1997). European Standard EN 1040. Chemical disinfectants and antiseptics, basic bactericidal activity. Test method and requirements (phase 1). European Committee for Standardisation. Brussels, Belgium
   Google Scholar
• El-Maghraby GM, Bary BW, Williams AC. (2008). Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 34:203–22
   PubMed Web of Science ®Google Scholar
• European Committee for Standardisation. (2015). PN-EN 13727:2012 + A1:2013. Chemical disinfectants and antiseptics – quantitative suspension test for the evaluation of bactericidal activity in the medical area. Test method and requirements (phase 2, step 1). 93/42/EEC. European Committee for Standardisation. Brussels, Belgium
   Google Scholar
• Franz T, Vogelin E. (2012). Aseptic tissue necrosis and chronic inflammation after irrigation of penetrating hand wounds using Octenisept®. J Hand Surg Eur 37:61–4
   Google Scholar
• Goldstein EJC, Citron DM, Nesbit CA. (1996). Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases. Diabetes Care 19:638–41
   PubMed Web of Science ®Google Scholar
• Hansen D, Patzke PI, Werfel U, et al (2007). Success of MRSA eradication in hospital routine: depends on compliance. Infection 35:260–4
   PubMed Web of Science ®Google Scholar
• Harker J. (2001). The effect of bacteria on leg ulcer healing. Br J Community Nurs 6:126–34
   PubMedGoogle Scholar
• Hartmann M, Berditsch M, Hawecker J, et al (2010). Damage of the bacterial cell envelope by antimicrobial peptides gramicidin S and PGLa as revealed by transmission and scanning electron microscopy. Antimicrob Agents Chemother 54:3132–42
   PubMed Web of Science ®Google Scholar
• Herzog IM, Fridman M. (2014). Design and synthesis of membrane-targeting antibiotics: from peptides- to aminosugar-based antimicrobial cationic amphiphiles. MedChemComm 5:1014–26
   Web of Science ®Google Scholar
• Hirsch T, Spielmann M, Zuhaili B, et al (2008). Enhanced susceptibility to infections in a diabetic wound healing model. BMC Surgery 8:5
   PubMedGoogle Scholar
• Klebes M, Ulrich C, Kluschke F, et al (2015). Combined antibacterial effects of tissue-tolerable plasma and a modern conventional liquid antiseptic on chronic wound treatment. J Biophotonics 8:382–91
   PubMed Web of Science ®Google Scholar
• Koburger T, Hubner NO, Braun M, Siebert J, Kramer A. (2010). Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. J Antimicrob Chemother 65:1712–19
   PubMed Web of Science ®Google Scholar
• Lachapelle JM. (2014). A comparison of the irritant and allergenic properties of antiseptics. Eur J Dermatol 24:3–9
   PubMed Web of Science ®Google Scholar
• Lakowicz JR. (2006). Principles of fluorescence spectroscopy. New York, NY: Springer US
   Google Scholar
• Marsh D. (2011). Pivotal surfaces in inverse hexagonal and cubic phases of phospholipids and glycolipids. Chem Phys Lipids 164:177–183
   PubMed Web of Science ®Google Scholar
• Moritz S, Wiegand C, Wesarg F, et al (2014). Active wound dressings based on bacterial nanocellulose as drug delivery system for octenidine. Int J Pharm 471:45–55
   PubMed Web of Science ®Google Scholar
• Nigam A, Gupta D, Sharma A. (2014). Treatment of infectious disease: beyond antibiotics. Microbiol Res 169:643–651
   PubMed Web of Science ®Google Scholar
• Parlakgumus A, Baykal A, Aran O. (2005). An unusual cause of chemical peritonitis. Acta Chir Belg 105:322–323
   PubMed Web of Science ®Google Scholar
• Pittena F, Wernerb H, Kramer A. (2003). A standardized test to assess the impact of different organic challenges on the antimicrobial activity of antiseptics. J Hosp Infect 55:108–115
   PubMed Web of Science ®Google Scholar
• Rigopoulos D, Rallis E, Gregoriou S, et al (2009). Treatment of pseudomonas nail infections with 0.1% octenidine dihydrochloride solution. Dermatology 218:67–68
   PubMed Web of Science ®Google Scholar
• Schmid H, Romanos A, Schiffl H, Lederer SR. (2013). Persistent nasal methicillin-resistant Staphylococcus aureus carriage in hemodialysis outpatients: a predictor of worse outcome. BMC Nephrol 14:93
   PubMed Web of Science ®Google Scholar
• Scognamiglio J, Jones L, Letizia CS, Api AM. (2012). Fragrance material review on 2-phenoxyethanol. Food Chem Toxicol 50:S244–S255
   PubMedGoogle Scholar
• Sen K, Mandal M. (2013). Second generation liposomal cancer therapeutics: transition from laboratory to clinic. Int J Pharm 448:28–43
   PubMed Web of Science ®Google Scholar
• Todoroff J, Vanbever R. (2011). Fate of nanomedicines in the lung. Curr Opin Coll Interface Sci 16:246–254
   Web of Science ®Google Scholar